Sort
30,917 grants matching “tumor microenvironment”
Co-Clinical Research Resource for Imaging Tumor Associated Macrophages
$617,354Heike Elizabeth Daldrup-Link · Stanford University · U24 · FY2024 · CA
A phase I study of RNA-lipid particle vaccines for newly-diagnosed glioblastoma, IND19304 08/21/2020
$617,119Elias Sayour · University Of Florida · R01 · FY2024 · FD
Clinically Translatable Ultrasound-Sensitive Microbubble Approaches for Overcoming Tumor Hypoxia
$617,101John Eisenbrey · Thomas Jefferson University · R01 · FY2020 · EB
The linkage between Race, Kaiso and the tumor microenvironment in breast cancer health disparities
$617,044Kevin L. Gardner · Columbia University Health Sciences · R01 · FY2021 · CA
A Statistical Physics Framework for Understanding the Role of Repeat RNA in Tumor Immunity
$617,031Benjamin Greenbaum · Sloan-Kettering Inst Can Research · U01 · FY2024 · CA
(PQC5) Detecting small clusters of tumor cells with a PTPmu probe
$616,995Susann M Brady-Kalnay · Case Western Reserve University · R01 · FY2015 · CA
Synthetic Compartments to Rewire Inflammatory Signaling and Augment Immune Cell Function
$616,897Matthew Charlton Good · University Of Pennsylvania · R56 · FY2025 · EB
TME CoBRE Administration Core
$616,793Paul R Lockman · West Virginia University · P20 · FY2019 · GM
Overcoming the immune-suppressive tumor microenvironment through in situ vaccination nanotechnology
$616,764Nicole Franziska Steinmetz · Case Western Reserve University · U01 · FY2017 · CA
(PQ6) Mesenchymal stem cell based and immunocompetent mouse models of HIV/AIDS KSHV-driven sarcomagenesis
$616,751Noula Dattu Shembade · University Of Miami School Of Medicine · R01 · FY2025 · CA
Applying pathomics to establish a biosignature for aggressive skin melanoma
$616,736Yvonne Margaret Saenger · Albert Einstein College Of Medicine · R01 · FY2023 · CA
Microbial-inspired immune-stimulating antibody-toxin conjugate (ATC) for cancer immunotherapy
$616,715Betty Kim · University Of Tx Md Anderson Can Ctr · R01 · FY2025 · CA
Novel dietary interventions for reducing obesity-associated breast cancer
$616,579Paul S Maclean · University Of Colorado Denver · R01 · FY2023 · CA
Deregulation of Sulfatide Synthesis in the Development and Progression of Pancreatic Cancer Precursor Lesions
$616,495Johannes F Fahrmann · University Of Tx Md Anderson Can Ctr · R01 · FY2025 · CA
Spatially resolved, single cell biomarkers of B cell lymphoma
$616,249Akil Merchant · Cedars-Sinai Medical Center · R01 · FY2022 · CA
A model for predicting response to PD-1 inhibitors in NSCLC
$616,200Edward B Garon · University Of California Los Angeles · R01 · FY2019 · CA
Quantitative Multimodal Imaging Biomarkers for Combined Locoregional and Immunotherapy of Liver Cancer
$616,121James S Duncan · Yale University · R01 · FY2022 · CA
The Core of the Computational Biology
$616,117Stephen Tc Wong · Methodist Hospital Research Institute · U54 · FY2012 · CA
Developing purinergic receptor inverse agonists for treating triple negative breast cancer
$616,071Jean X Jiang · University Of Texas Hlth Science Center · R01 · FY2025 · CA
First-in-Class CD206 Agonist for Immunologically Cold Solid Organ Cancers
$616,056Sharie Haugabook · National Center For Advancing Translational Sciences · ZIA · FY2025 · TR
Novel Approaches to Targeting Cancers Associated with VHL Mutations
$615,955Ramaprasad Srinivasan · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Environmental Chemical Body Burden and Prospective Breast Cancer Risk in the Cancer Prevention Study-3 Cohort
$615,930Susan L. Neuhausen · Beckman Research Institute/City Of Hope · R01 · FY2025 · ES
Diversity of the Tumor Microenvironment in Cancer Progression and Metastasis
$615,883Christina S Leslie · Sloan-Kettering Inst Can Research · U54 · FY2014 · CA
Design and characterization of bacterial population dynamics in solid tumor models
$615,868Jeff M Hasty · University Of California, San Diego · R01 · FY2024 · EB
A âSTICKâ theranostic nanoplatform for image-guided drug delivery to brain malignancies
$615,825Yuanpei Li · University Of California At Davis · R01 · FY2025 · EB